Looking At AbbVie's Recent Unusual Options Activity - AbbVie (NYSE:ABBV)

Core Insights - Investors are showing a bullish stance on AbbVie (NYSE:ABBV), indicating potential upcoming developments that may influence the stock price [1][2] - The options trading activity reveals a split sentiment among large investors, with 43% bullish and 43% bearish positions [3] Options Trading Activity - Benzinga's options scanner identified 16 uncommon options trades for AbbVie, with a total of $1,449,383 in call options and $97,520 in put options [2][3] - Major market movers are focusing on a price range between $120.0 and $250.0 for AbbVie over the last three months [4] - The volume and open interest data for AbbVie's options indicate significant liquidity and interest, particularly within the strike price range of $120.0 to $250.0 [5] Options Snapshot - Notable options trades include: - A bearish call sweep for a strike price of $220.00 with a total trade price of $293.4K [9] - A bullish call sweep for a strike price of $230.00 with a total trade price of $226.5K [9] - Additional bearish call sweeps for the same strike price of $220.00 with total trade prices of $190.9K and $183.3K [9] Company Overview - AbbVie is a pharmaceutical company with strong exposure in immunology and oncology, having expanded its portfolio through acquisitions, including Allergan in 2020 and recent acquisitions of Cerevel and ImmunoGen [10] - Current market consensus from analysts suggests a target price of $267.0 for AbbVie, with ratings from Morgan Stanley and HSBC indicating an Overweight and Buy rating, respectively [12][13] Current Market Performance - AbbVie’s stock price is currently at $225.83, reflecting a 0.97% increase with a trading volume of 2,394,007 [15] - The stock's current RSI values suggest a neutral position between overbought and oversold [15]